16 March 2026 in Journal of Investigative Medicine
Coronary artery calcium scoring (CCS) is a valuable non-invasive method for assessing atherosclerosis and performing risk stratification in patients with suspected coronary artery disease (CAD). Monocyte subsets play distinct roles in chronic inflammation and cardiovascular disease, potentially serving as biomarkers for CCS risk assessment. The aim of this study was to analyze the distribution of monocyte subsets in patients with suspected CAD and determine the association of monocyte subsets with CCS. A cohort of 182 individuals with suspected CAD was enrolled. Participants were stratified into three groups based on their CCS scores: very low-risk (CCS = 0), low-risk (CCS = 1−99), and moderate–high risk (CCS ≥ 100). Monocyte subsets were categorized according to CD14 and CD16 expression levels into classical, intermediate (intMo), and non-classical monocytes. Absolute counts and frequency distribution of monocyte subsets (FDMS, percentage of CD45+/CD14+/CD16+ events) were analyzed across all participants. Patients in the moderate–high risk CCS group had significantly higher absolute circulating monocyte counts than those in the other two groups ( p < 0.05). Furthermore, the moderate–high risk CCS group had the highest absolute intMo count and FDMS (percentage of CD45+/CD14+/CD16+ events, p < 0.05). Both the absolute intMo count (Model 1: odds ratio [OR] = 1.024, 95% confidence interval [CI]: 1.009−1.040, p = 0.002) and FDMS (percentage of CD45+/CD14+/CD16+ events, Model 2: OR = 1.109, 95% CI = 1.039−1.183, p = 0.002) were identified as independent risk factors for moderate–high risk CCS. These data suggest that intMo may be a useful biomarker for CCS risk stratification.
1 January 2024 in Journal of Interventional Cardiology
Objective: To compare the efficiency and safety of primary and bailout antegrade dissection and re‐entry (ADR) during percutaneous coronary intervention (PCI) for chronic total occluded (CTO) lesions.Methods: Patients who underwent ADR procedures for CTO lesions were enrolled in this study and were divided into two groups (primary ADR and bailout ADR) based on the initiation of ADR during PCI. The success rate and major adverse cardiovascular and cerebrovascular events (MACCE) during hospitalization were assessed as the primary endpoints. Procedure time, fluoroscopy time, wire crossing time, radiation dose, and contrast volume were considered as secondary endpoints.Results: A total of 243 patients were enrolled in this study, with 127 patients receiving primary ADR and 116 receiving bailout ADR. No differences were found in baseline parameters between the two groups. The success rate was significantly higher in the primary ADR group compared to the bailout ADR group (89.0% versus 77.6%, respectively; p = 0.017). The incidence of in‐hospital MACCE was low in both groups, with no significant differences observed between them. Procedure time, radiation dose, and contrast volume were lower in the primary ADR group compared to the bailout ADR group. Cox regression analysis revealed that primary ADR and J‐CTO score ≥ 3 were independent predictors of technical success in CTO‐PCI.Conclusions: Both primary and bailout ADR are safe strategies for CTO‐PCI. Primary ADR significantly improves the success rate of PCI for CTO compared to bailout ADR, with shorter operation time, lower radiation dose, and reduced contrast volume.